It's a signalling problem
Research progress Support The animal experiments have achieved remarkable results: In the obese mouse model, after daily subcutaneous injection of AOD 9604 (250 g/kg) for 8 weeks, the body weight of the mice decreased by 12%, the subcutaneous fat mass decreased by 25%, and the weight of epididymal adipose tissue significantly decreased, confirming its effectiveness in fat reduction
For physically active people, runners, or gym-goers, this is gold-standard information
Our research-grade NAD+ is produced under strict quality-controlled laboratory conditions and supplied as a stable lyophilized formulation to ensure maximum purity, consistency, and reproducibility across experimental applications
The psychological barrier to self-injection stops countless individuals from ever trying peptide therapy